Kulkarni P S, Srinivasan B D
Invest Ophthalmol Vis Sci. 1985 Aug;26(8):1178-82.
The effects of the prostaglandin (PG)-3 series products PGE3 and PGD3 on the intraocular pressure of rabbits were studied. PGE3 at 0.001 and 0.01 mg/eye and PGD3 at 0.01 and 0.05 mg/eye doses were applied topically (in 50-microliters volume) to the normal rabbit eye. Both PGE3 and PGD3 significantly lowered intraocular pressure at all doses tested and the IOP lowering response lasted at least 240 min. Topical PGE3 at 0.01 mg/eye caused mild conjunctival hyperemia which lasted up to 180 min. PGD3, on the other hand, did not induce conjunctival hyperemia. In addition, following application of these PGs, there was no miosis or other sign of intraocular inflammation detectable by slit-lamp examination.
研究了前列腺素(PG)-3系列产品前列腺素E3(PGE3)和前列腺素D3(PGD3)对兔眼压的影响。以0.001和0.01mg/眼的剂量以及0.01和0.05mg/眼的剂量,将PGE3和PGD3以50微升的体积局部应用于正常兔眼。在所有测试剂量下,PGE3和PGD3均能显著降低眼压,且眼压降低反应至少持续240分钟。0.01mg/眼的局部PGE3可引起轻度结膜充血,持续长达180分钟。另一方面,PGD3未诱发结膜充血。此外,应用这些前列腺素后,通过裂隙灯检查未发现瞳孔缩小或其他眼内炎症迹象。